1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
(
- Contribution to journal › Article
- 2018
-
Mark
Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice
(
- Contribution to journal › Article
- 2017
-
Mark
Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction
(
- Contribution to journal › Article
- 2016
-
Mark
High levels of cathepsin D and cystatin B are associated with increased risk of coronary events.
(
- Contribution to journal › Article
-
Mark
High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy.
(
- Contribution to journal › Article
- 2015
-
Mark
IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice.
(
- Contribution to journal › Article
-
Mark
High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.
(
- Contribution to journal › Article
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
(
- Contribution to journal › Article